POLA PERESEPAN ANTIHIPERTENSI PADA PASIEN PREEKLAMPSIA DI INSTALASI RAWAT INAP RSUD DR. MOEWARDI SURAKARTA TAHUN 2019

Vika, Suryaningtyas (2020) POLA PERESEPAN ANTIHIPERTENSI PADA PASIEN PREEKLAMPSIA DI INSTALASI RAWAT INAP RSUD DR. MOEWARDI SURAKARTA TAHUN 2019. Diploma thesis, Sekolah Tinggi Ilmu Kesehatan Nasional.

	Text KTI.pdf Download (814kB)
	Text Fulltext Vika Suryaningtyas.pdf Restricted to Repository staff only Download (2MB)

Abstract

Preeclampsia is defined as hypertension accompanied by proteinuria, is a multisystem disorder that occurs after 20 weeks gestation. Hypertension causes a decrease in blood supply and oxygen to the placenta and food to the fetus causing fetal development is hampered and preterm labor occurs, so the selection of drugs used must be safe and effective, so that this study was conducted to determine the type of drug given and the percentage of antihypertensive drug prescribing patterns in preeclampsia patients in the Inpatient Installation Dr. Moewardi Surakarta period 2019 based on the main standard of POGI 2016. The method used in this study is a descriptive non-experimental research method. Retrospective data collection by looking at prescription data for preeclampsia patients through SIMRS RSUD DR. Moewardi Surakarta. The characteristics of hypertension patients in this study were peeklampsia patients aged 21-35 years as many as 47 cases with a percentage of 58.02%. The results showed that the use of antihypertensive drugs in the Calcium Channel Blocker (CCB) group was nifedipine at 48.17%, and the second group that was the most widely used was the alpha 2 receptor agonist group namely methyldopa at 29.88%. The prescription for monotherapy is CCB, nifedipine in 24 cases or 29.63%. Prescribing that is widely used as a combination therapy is the CCB group (nifedipine) and alpha 2 receptor agonist (methyldopa) as many as 39 cases with a percentage of 41.98%.

Actions (login required)

View Item